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Abstract
In an analysis of the clinical and laboratory variables that can influence the response to interferon alfa-2b treatment, 48 patients with chronic hepatitis C virus infection received interferon 5 million units (MU) subcutaneously three times weekly for eight weeks followed by 3 MU three times weekly for seven months. Response related factors on univariate analysis were found to be age >40 years, non-parenteral source of infection, pretreatment positive antinuclear antibodies (ANA), cirrhosis, and high serum iron, ferritin, gamma glutamyl transferase, and IgM. An independent predictive value (multivariate analysis) was also found for cirrhosis, ANA, serum iron, and ferritin. A baseline aspartate aminotransferase/ alanine aminoransferase ratio of 0.5 and a striking increase during interferon treatment were associated with a complete response.
(Gut 1993; supplement: S139-S140)
The influence of clinical and laboratory variables on the response to interferon was analysed in patients with chronic hepatitis C who were positive for antibodies to hepatitis C virus (anti-HCV) on both ELISA-2 and RIBA-2. (Figure) . 
